[1] |
Foroozan R. Chiasmal syndromes[J]. Curr Opin Ophthalmol,2003, 14:325-331.
|
[2] |
Gedik S, Gur S, Atalay B, et al. Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma[J]. Saudi Med J,2007,28:1380-1384.
|
[3] |
Chiu EK, Nichols JW. Sellar lesions and visual loss: key concepts in neuro-ophthalmology[J]. Expert Rev Anticancer Ther,2006,6:S23-28.
|
[4] |
Huang WC, Lee LS. Visual field defects in patients with pituitary adenomas[J]. Zhonghua Yi Xue Za Zhi (Taipei),1997,60:245-251.
|
[5] |
Perkins TW. CLinical decisions in glaucoma[J]. Arch Ophthalmol,1994,112:1518-1519.
|
[6] |
于强,叶天才,李绍珍,等. 青光眼与生存质量的关系[J]. 眼科学报,1996,12:183-183.
|
[7] |
Monteiro ML, Zambon BK, Cunha LP. Predictive factors for the development of visual loss in patients with pituitary macro-adenomas and for visual recovery after optic pathway decompression[J]. Can J Ophthalmol,2010,45:404-408.
|
[8] |
Poon A, McNeill P, Harper A, et al. Patterns of visual loss associated with pituitary macroadenomas[J]. Aust N Z J Ophthalmol,1995,23:107-115.
|
[9] |
Schmalisch K, Milian M, Schimitzek T, et al. Predictors for visual dysfunction in nonfunctioning pituitary adenomas- implications for neurosurgical management[J]. Clin Endocrinol (Oxf),2012,77:728-734.
|
[10] |
李莉. 垂体瘤致视力功能障碍45例临床分析[J]. 中国实用医刊,2008,35:48-49.
|
[11] |
Nishimura M, Kurimoto T, Yamagata Y, et al. Giant pituitary adenoma manifesting as homonymous hemianopia[J]. Jap J Ophthalmol,2007,51:151-153.
|
[12] |
Lee JP, Park IW, Chung YS. The volume of tumor mass and visual field defect in patients with pituitary macroadenoma[J]. Korean J Ophthalmol,2011,25:37-41.
|
[13] |
Ogra S, Nichols AD, Stylli S, et al. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma[J]. J Clin Neurosci,2014,21:735-740.
|